MedTrace Logo

Fecal Transplant for Crohn's Disease

NCT03078803 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-09-07

No results posted yet for this study

Summary

To determine the efficacy and safety of serial FMT at inducing and maintaining clinical and endoscopic response in patients with mild to moderate Crohn's disease

Conditions

  • Crohn Disease

Interventions

BIOLOGICAL

Fecal Microbiota Transplant (FMT)

FMT delivered by colonoscopy and oral capsules

BIOLOGICAL

Placebo

Transfer of water only

Sponsors & Collaborators

  • University of Calgary

    collaborator OTHER

  • McMaster University

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Dina Kao, MD · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-28
Primary Completion
2021-06-21
Completion
2022-08-29

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078803 on ClinicalTrials.gov